snsinsider 님의 블로그

The Artificial Intelligence (AI) in Breast Imaging Market Revenue was valued at USD 423.9 million in 2023 and is expected to experience significant growth, reaching USD 1886.4 million by 2032, growing at a compound annual growth rate (CAGR) of 16.1% during the forecast period of 2024 to 2032. The increasing demand for more accurate and efficient breast cancer detection, along with advancements i..

The Cell Therapy Human Raw Materials Market Revenue was valued at USD 2.9 billion in 2023 and is anticipated to experience substantial growth, reaching USD 18.1 billion by 2032. This represents a remarkable CAGR of 22.6% during the forecast period from 2024 to 2032. The market growth is attributed to the increasing demand for cell-based therapies, advancements in regenerative medicine, and the e..

The Automated Liquid Handling Technologies Market Revenue was valued at USD 2.11 billion in 2023 and is projected to reach USD 5.24 billion by 2032, registering a robust CAGR of 11.18% during the forecast period from 2024 to 2032. The demand for automated liquid handling systems is rapidly increasing, driven by their ability to enhance laboratory efficiency, ensure precision, and reduce errors i..

The gRNA Market Revenue was valued at USD 498.30 million in 2023 and is projected to experience exponential growth, reaching USD 2,303.70 million by 2032 with a remarkable CAGR of 19.61% over the forecast period of 2024-2032. The growing adoption of gene-editing technologies and increased focus on precision medicine are key drivers contributing to the robust expansion of the guide RNA (gRNA) mar..

The Biological Safety Testing Products and Services Market Revenue was valued at $4.42 billion in 2023 and is projected to expand significantly, reaching $10.51 billion by 2032, with a robust CAGR of 10.10% over the forecast period of 2024-2032. This growth is primarily driven by the rising focus on biopharmaceutical development, stringent regulatory guidelines, and the need for safe and reliabl..

The Cell Therapy Market Revenue was valued at USD 4.65 billion in 2023 and is expected to reach an impressive USD 28.98 billion by 2032, growing at a staggering CAGR of 22.55% over the forecast period 2024-2032. This robust growth is fueled by advancements in regenerative medicine, increasing prevalence of chronic diseases, and the rising demand for personalized treatment solutions.Key Drivers o..

The Alzheimer’s Therapeutics Market Revenue was valued at USD 3.78 billion in 2023 and is projected to grow exponentially, reaching USD 13.42 billion by 2032, at a robust CAGR of 15.14% during the forecast period 2024-2032. This growth is driven by increasing investments in research and development, a growing aging population, and advancements in therapeutic approaches aimed at addressing Alzhei..

The Generative AI in Healthcare Market Revenue was valued at USD 1.7 billion in 2023 and is anticipated to reach a staggering USD 19.99 billion by 2032, exhibiting an impressive CAGR of 31.5% during the forecast period from 2024 to 2032. The transformative potential of generative AI in reshaping healthcare services, ranging from diagnostics to personalized treatments, is driving the market’s rap..

The Respiratory Devices Market Revenue was valued at USD 22.62 billion in 2023 and is forecasted to nearly double, reaching USD 46.10 billion by 2032 at a CAGR of 8.27% during the forecast period of 2024-2032. The rising prevalence of respiratory disorders, technological advancements in respiratory care devices, and the increasing adoption of home healthcare solutions are driving market growth g..

The Healthcare Waste Management Market Revenue was valued at USD 34.08 billion in 2023 and is projected to double, reaching USD 68.03 billion by 2032, with a CAGR of 8.36% during the forecast period of 2024-2032. This growth is fueled by increasing healthcare activities worldwide, stringent regulatory frameworks for waste management, and rising awareness of sustainable practices in healthcare fa..